Kisoji Biotechnology logo
Portfolio company

Kisoji Biotechnology

Details
Region
Ontario
Industry sector
Medical/health
Investment year
2016
Fund
Seed Venture Fund
Learn more
Lead
Dinar Ahmed - Principal, venture capital at BDC
Dinar Ahmed

Partner

View profile
About the company

Kisoji is a leading next-generation antibody company developing multi-specific antibodies to address difficult targets in oncology and other diseases.

Your privacy

BDC uses cookies to improve your experience on its website and for advertising purposes, to offer you products or services that are relevant to you. By clicking ῝I understand῎ or by continuing to browse this site, you consent to their use.

To find out more, consult our Policy on confidentiality.